key words | Vol. No. | page | report | |
A chart to evaluate magnitude and quality of TB and its control | Vol.75 No.07 | 483-491 | Tadao SHIMAO | Fifty Years of Research on Tuberculosis-Lessons I Have Learnt during 50 Years and Topics to be Investigated in the Future |
Abdominal lymph node tuberculosis | Vol.81 No.11 | 667-671 | Junichi TSUYUSAKI et al. | A Case of Disseminated Tuberculosis Complicated with Tuberculous Meningitis while Investigating an Abdominal Lymphadenopathy |
Abdominal lymph node tuberculosis | Vol.87 No.11 | 707-712 | Yasuo SHIMIZU et al. | PET/CT FOR MONITORING THE THERAPEUTIC RESPONSE IN A PATIENT WITH ABDOMINAL LYMPH NODE TUBERCULOSIS AFTER COLON CANCER RESECTION |
Abdominal lymphadenitis | Vol.84 No.10 | 675-679 | Masafumi HORIE et al. | A Case of tuberculosis with Multiple Lung Nodules Abdominal Lymphadenopathy and Sprenomegaly |
Abdominal wall tuberculosis | Vol.85 No.06 | 553-557, | Kazuyoshi
NAKAMURA and Tohru YAMANAKA |
A Case of Abdominal Tuberculosis Relapsed after Resection |
Abnormality of NEMO gene | Vol.84 No.08 | 597-603 | Shigehiro ENKAI et al. | A Case of Disseminated BCG Infection Found during Treatment of an Infant with Crohn's Disease |
Abolition of BCG revaccination | Vol.77 No.10 | 639-645 | Keiko NISHIO et al. | Problems About Tuberculin Skin Test Raised form Consultations and Countermeasures-Influence to the Interpretation of Tuberculin Skin Test in Case of the Stoppage of BCG Revaccination Abolition and the Introduction of Induration Measurement |
Accelerometer-built-in pulse oxymeter | Vol.80 No.06 | 491-497 | Takeo KAWASHIRO | Evaluation of Respiratory Failure Due to Sequelae of Tuberculosis |
Accompanied disease | Vol.85 No.02 | 95-111 | Katsuyuki TOBISE and Seiya KATO | MEDICAL SERVICE SYSTEM UNDER INFECTIOUS DISEASES LAW |
Acguired immunity | Vol.85 No.06 | 501-508, | Masaji OKADA | Immunity against Mycobacterium Tuberculosis (INTRODUCTION) |
Acid-fast bacilli | Vol.80 No.02 | 95-111 | Chairpersons:S. ICHIYAMA and K. SUZUKI | Clinical Application of Testing Methods on Acid-Fast Bacteria |
Acid-fast bacterium testing | Vol.79 No.02 | 33-37 | Tetsuhisa HIROOKA et al. | The Value of Proper Sputum Collection Instruction in Detection of Acid-Fast Bacillus |
Acid-fast staining | Vol.78 No.08 | 533-539 | Atsuyuki KURASHIMA et al. | Comparative Evaluation of the Isothermal and Chimeric Primer-Initiated Amplification of Nucleic Acids (ICAN®) and Roche Amplicor® PCR and Culture for Detecting Mycobacterium tuberculosis Complex in Sputum Samples |
Acinar lesion | Vol.84 No.08 | 551-557 | Hitoshi TOKUDA | Various Aspects of Acinar Lesions -The Key Finding of Pulmonary tuberculosis on HRCT- |
Acinus | Vol.81 No.07 | 491-497 | Jiro FUJITA | Clinicoradiological Diagnosis of Respiratory Infections:Estimate of Pathogens by Radiological Findings and the Strategy for Treatment |
Acquired drug resistance | Vol.79 No.12 | 717-724 | Takashi YOSHIYAMA et al. | Process of Acquiring Drug Resistance, Retrospective Review of Records of MDR TB |
Acquired drug resistance | Vol.79 No.09 | 561-567 | Kunihiko ITO et al. | Miss-managements in Treatment Failure of Pulmonary Tuberculosis |
Acquired drug resistance | Vol.80 No.01 | 9-14 | Takashi YOSHIYAMA et al. | Risk of Acquisition of RFP Resistance Out of INH Resistant RFP Susceptible Tuberculosis |
Acquired Immune Deficiency Syndrome | Vol.82 No.12 | 903-918 | Kenji HIBIYA et al. | The Pathogenesis
and the Development Mechanism of Mycobacterium avium Complex Infection |
Acquired Immune Deficiency Syndrome | Vol.82 No.12 | 903-918 | Kenji HIBIYA et al. | The Pathogenesis
and the Development Mechanism of Mycobacterium avium Complex Infection |
Acquired immunodeficiency syndrome | Vol.78 No.01 | 45-49 | Hideaki NAGAI | HIV Infection and Tuberculosis |
Acquired immunodeficiency syndrome | Vol.82 No.01 | 27-31 | Hirokazu TANIGUCHI et al. | A Case of Tuberculosis Showing Immune Reconstitution Syndrome after the Initiation of Antiretroviral Therapy for HIV Infection |
Acquired resistance | Vol.78 No.02 | 83-87 | Makoto YONEMARU et al. | Trends in Drug-Resistant Tuberculosis in National Higashisaitama Hospital, 1994-2001 |
Active case-finding | Vol.86 No.12 | 971-981 | Chairpersons: 1 Tadayuki AHIKO and 2 Tomoyo NARITA | The 86th Annual Meeting Mini-Symposium - COOPERATION OF RELEVANT ORGANIZATIONS FOR TUBERCULOSIS CONTROL |
Active case finding | Vol.78 No.06 | 427-434 | Takashi YOSHIYAMA et al. | A Comparative Study on Severity of Tuberculosis Cases between Those Found by Periodical Chest X-ray Examination and Those Found by Symptomatic Visit to OPD in Japan |
Active case finding for contacts | Vol.79 No.09 | 579-586 | Masaki OTA et al. | An Outbreak of Tuberculosis in a Long-term Care Unit of a Mental Hospital |
Active lung tuberculosis | Vol.79 No.04 | 309-311 | Kunihiko ITO et al. | C-Reactive Protein in Patients with Bacteriological Positive Lung Tuberculosis |
Active pulmonary mycobacteriosis | Vol.80 No.05 | 413-419 | Atsuhisa TAMURA et al. | Coexistence of Lung Cancer and Active Pulmonary Mycobacteriosis |
Active pulmonary tuberculosis | Vol.76 No.06 | 479-484 | Hiroshi MIZUTANI et al. | A case of Tuberculous Peritonitis Diagnosed by a Direct Smear of Ascitic Fluid Complicated with an Active Pulmonary Tuberculosis and Intestinal Tuberculosis |
Active pulmonary tuberculosis | Vol.76 No.09 | 619-624 | Mouka TAMURA et al. | A Study on Relation between Active Pulmonary Tuberculosis and Underlying Diseases |
Active pulmonary tuberculosis | Vol.77 No.12 | 771-775 | Yoshihiro KOBASHI et al. | Clinical Evaluation of the Cause of Death in Patients with Active Pulmonary Tuberculosis |
Active pulmonary tuberculosis | Vol.78 No.02 | 101-105 | Kazuko MACHIDA | Management of Respiratory Failure in Patients with Pulmonary Tuberculosis |
Active pulmonary tuberculosis | Vol.86 No.07 | 717-722 | Yoshitoshi KOMAZAKI et al. | PULMONARY THROMBOEMBOLISM WITH PULMONARY TUBERCULOSIS |
Active tuberculosis | Vol.86 No.02 | 45-50 | Akihiro ITO et. al. | ANALYSIS OF USEFULNESS OF A WHOLE BLOOD INTERFERON GAMMA ASSAY (QuantiFERON® TB-2G) FOR DIAGNOSING ACTIVE TUBERCULOSIS IN IMMUNOCOMPROMISED PATIENTS |
Activity classification | Vol.85 No.07 | 631-634, | Tadao SHIMAO | Start of TB Case-Registration and Case-Management System in Japan |
Actual status of onset of disease | Vol.78 No.11 | 691-697 | Shinji SHISHIDO et al. | A Survey on the Onset of Tuberculosis in Nursing Homes |
Acute respiratory distress syndrome | Vol.87 No.12 | 771-776 | Sachiko SHIRAISHI et al. | A CASE OF MILIARY TUBERCULOSIS COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATION AND ACUTE RESPIRATORY DISTRESS SYNDROME SUCCESSFULLY TREATED WITH RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN |
Acute respiratory distress syndrome(ARDS) | Vol.75 No.05 | 395-401 | Goh TANAKA et al. | Acute Respiratory Failure Caused by Tuberculosis Requiring Mechanical Ventilation |
Acute respiratory failure | Vol.78 No.02 | 101-105 | Kazuko MACHIDA | Management of Respiratory Failure in Patients with Pulmonary Tuberculosis |
ADA | Vol.80 No.12 | 731-734 | Naohiko INASE et al. | Adenosine Deaminase 2 in the Diagnosis of Tuberculous Pleuritis |
ADA | Vol.86 No.02 | 57-60 | Kazumi NISHIO et. al. | A CASE HAVING CHYLIFORM PLEURAL EFFUSION CAUSED BY FORMER TUBERCULOUS PLEURISY |
ADA | Vol.86 No.04 | 431-436 | Satoko YONESHIMA et.al. | CLINICAL REVIEW OF 8 PATIENTS WITH TUBERCULOUS PERITONITIS |
ADA levels of pleural effusion | Vol.88 No.04 | 423-427 | Kazuyoshi NAKAMURA et al. | A CASE OF TUBERCULOUS PLEURISY DISTINGUISHED FROM PLEURISY CAUSED BY MYCOPLASMA INFECTION |
ADA2 | Vol.80 No.12 | 731-734 | Naohiko INASE et al. | Adenosine Deaminase 2 in the Diagnosis of Tuberculous Pleuritis |
Adenosine deaminase | Vol.78 No.05 | 407-410 | Shuichi YANO et al. | A Case of Tuberculous Pericarditis, the Diagnosis of which was Complicated by the Delay in the Rise of Adenosine Deaminase in the Pericardial Effusion |
Adenosine deaminase | Vol.80 No.11 | 695-699 | Motoaki TANIGAWA et al. | A Case of Tuberculous Peritonitis |
Adenosine deaminase | Vol.87 No.12 | 765-769 | Takeharu KOGA et al. | A CASE OF TUBERCULOUS PERITONITIS ACCOMPANIED BY LYMPHADENITIS IN A PATIENT WITH LIVER CIRRHOSIS IN WHICH LYMPH NODE BIOPSY WAS USEFUL FOR ESTABLISHING THE DIAGNOSIS |
Adenosine deaminase 2 | Vol.80 No.12 | 731-734 | Naohiko INASE et al. | Adenosine Deaminase 2 in the Diagnosis of Tuberculous Pleuritis |
Adherence | Vol.86 No.10 | 815-820 | Kenji MATSUMOTO et al. | ASSESSMENT OF SELF-DISCHARGE OF HOMELESS PATIENTS WITH TUBERCULOSIS |
Administration of drug | Vol.78 No.09 | 581-585 | Emiko TOYOTA et al. | Usefulness of Directly Observed Therapy (DOT) during Hospitalization as DOTS in Japanese Style |
Admission period | Vol.80 No.09 | 595-600 | Toshiaki FUJIKANE et al. | The Improvement of the Enforcement Rate of the Standard Regimen (A) of Tuberculosis Chemotherapy by the Introduction of Common Database System for Tuberculosis |
Admission periods | Vol.81 No.12 | 715-720 | Eriko MORINO et al. | Effects of New Discharge Criteria Incorporating DOTS on Treatment Outcome of Patients with Smear-Positive Tuberculosis |
Adverse drug reaction | Vol.87 No.07 | 487-490 | Hiraku ICHIKI et al. | STUDY OF ADVERSE DRUG REACTIONS IN THE TREATMENT OF PULMONARY MYCOBACTERIUM AVIUM COMPLEX DISEASE |
Adverse effect | Vol.75 No.09 | 521-526 | Yoshihiro KOBASHI et al. | Desensitization Therapy for Antituberculous Drugs |
Adverse effect | Vol.81 No.11 | 651-660 | Kunihiko ITO et al. | Liver Damage in Treatment of Latent Tuberculous Infection by Isoniazid |
Adverse effect | Vol.82 No.01 | 1-9 | Kunihiko ITO et al. | Adverse Effect Other than Liver Dysfunction in Treatment of Latent Tuberculous Infection by Isoniazid |
Adverse effect | Vol.83 No.01 | 21-25 | Junichi FUJITA et al. | A Case of Multi-drug Resistant Tuberculosis Showing Psychiatric Adverse Effect by Cycloserine |
Adverse effects | Vol.86 No.02 | 87-99 | Chairpersons: K. TSUYUGUCHI and M. WADA |
MANAGEMENT OF ADVERSE EFFECTS WITH ANTITUBERCULOSIS CHEMOTHERAPY |
Adverse effects | Vol.86 No.05 | 499-507 | Yoshiaki YAMAMOTO et al. | RETROSPECTIVE COHORT STUDY OF RISK FACTORS FOR ADVERSE EFFECTS OF ANTITUBERCULOUS THERAPY |
Adverse events | Vol.81 No.05 | 363-369 | Masako WADA et al. | Twice-Weekly Intermittent Chemotherapy during the Maintenance Phase of the Short-Course Treatment for New Patients with Pulmonary Tuberculosis |
Adverse reactions | Vol.82 No.11 | 809-824 | Ichiro TOIDA et al. | Severe Adverse Reactions after Vaccination with Japanese BCG Vaccine: A Review |
Adverse reactions | Vol.77 No.10 | 647-658 | Masako OHMORI et al. | Preventive Therapy in Middle-Aged and Elderly Persons Selected from the Population-Based Screening by Mass Miniature Radiography-Methodological Aspect and Adverse Reactions |
Adverse reactions to purified protein derivative | Vol.76 No.08 | 563-569 | Hisashi FUNADA et al. | Two-Step Tuberculin Testing and BCG Vaccination in the Personnel of a Medical and Pharmaceutical University |
Advisory documents to physicians | Vol.77 No.08 | 555-561 | Chika SHIRAI | Tuberculosis Control in Kobe City-Analysis of Advisory Contents and Disqualified Cases by Integrated Tuberculosis Advisory Committee |
Aerosol infection | Vol.77 No.08 | 585-588 | Isamu SUGAWARA | Study on the Roles of Cytokines Involved in Mycobacterial Infection |
Age | Vol.84 No.12 | 795-798 | Tuberculosis Surveillance Center | TUBERCULOSIS
ANNUAL REPORT 2008 ─ Series 3. Childhood TB─ |
Age | Vol.85 No.01 | 61-64 | Tuberculosis Surveillance Center | TUBERCULOSIS
ANNUAL REPORT 2008 ─ Series 4. Elderly TB ─ |
Age | Vol.85 No.02 | 139-142 | Tuberculosis Surveillance Center | TUBERCULOSIS ANNUAL REPORT 2008 |
Age | Vol.85 No.03 | 213-216, | Tuberculosis
Surveillance Center, RIT,JATA |
Tuberculosis Annual Report 2008 -Series6. Condition of TB(1)- |
Age | Vol.85 No.05 | 495-498, | Tuberculosis
Surveillance Center,RIT,JATA |
Tuberculosis Annual Report 2008 -Series7. Condition of TB(2)- |
Age | Vol.86 No.05 | 553-556 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ―Series 3. Childhood TB― |
Age | Vol.86 No.07 | 737-741 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ―Series 4. Elderly TB― |
Age | Vol.86 No.09 | 787-791 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ─ Series 5. Case Findings ─ |
Age | Vol.86 No.10 | 835-838 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ─ Series 6. Condition of TB (1) ─ |
Age | Vol.86 No.11 | 883-887 | Tuberculosis Surveillance Center | TUBERCULOSIS ANNUAL REPORT 2009 ─Series7. Condition of TB(2)─ |
Age | Vol.87 No.02 | 57-60 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ─Series 8. Treatment of TB (1)─ |
Age | Vol.87 No.04 | 351-355 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ─Series 9. Treatment of TB (2)─ |
Age | Vol.87 No.04 | 357-365 | Masako OHMORI et al. | THE BACKGROUND OF DRUG-RESISTANT TUBERCULOSIS PATIENTS ON THE BASIS OF THE ANNUAL REPORT DATABASE FOR 2007-2009 IN JAPAN |
Age | Vol.87 No.08 | 549-553 | Tuberculosis Surveillance Center (TSC), RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2010 ─(3) Childhood Tuberculosis─ |
Age | Vol.87 No.11 | 743-746 | Tuberculosis Surveillance | TUBERCULOSIS ANNUAL REPORT 2010 ─ (6) Tuberculosis Characteristics upon Diagnosis-1 ─ |
Age | Vol.87 No.12 | 783-787 | Tuberculosis Surveillance | TUBERCULOSIS ANNUAL REPORT 2010 ─ (7) Tuberculosis Characteristics upon Diagnosis-2 ─ |
Age | Vol.88 No.03 | 311-314 | Tuberculosis Surveillance Center (TSC), RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2010 ─ (8) Treatment of Tuberculosis-1- |
Age | Vol.88 No.04 | 439-443 | Tuberculosis Surveillance Center (TSC), RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2010 ─ (9) Treatment of Tuberculosis ─ 2 ─ |
Aged population | Vol.76 No.04 | 371-375 | Mie KASAMATSU et al. | Analysis of Factors Related to the High Incidence of Tuberculosis in the City of Wakayama-Analysis According to Age Groups, and Sputum Test Results |
Aging | Vol.81 No.09 | 567-571 | Takeo INOUE et al. | Influence of Aging on Tuberculosis Infection-An Epidemiological Study of 1,141 Smear-positive TB Patients- |
Aging | Vol.84 No.06 | 477-484 | Takeo INOUE et al. | Generation-to-generation TB transmission in Aichi, Central Japan |
Aging | Vol.85 No.08 | 655-660 | Emiko TOYOTA et al. | CLINICAL INVESTIGATION AMONG ELDERLY PATIENTS WITH TUBERCULOSIS |
Agranulocytosis | Vol.78 No.11 | 683-689 | Yuichiro SHISHIDO et al. | Agranulocytosis Due to Anti-Tuberculosis Drugs Including Isoniazid (INH) and Rifampicin (RFP)-A Report of Four Cases and Review of the Literature- |
Agranulocytosis | Vol.87 No.11 | 719-725 | Masafumi SUGIYAMA | A CASE OF AGRANULOCYTOSIS
CAUSED BY RIFAMPICIN DURING TREATMENT OF TUBERCULOUS LYMPHADENITIS IN A CHRONIC RENAL FAILURE PATIENT |
AIDS | Vol.75 No.09 | 547-556 | Koh NAKATA et al. | Tuberculosis in Patients with Acquired Immune Deficiency Syndrome |
AIDS | Vol.76 No.11 | 679-684 | Hideaki NAGAI et al. | HIV Seroprevalence in Patients with Tuberculosis |
AIDS | Vol.77 No.01 | 37-40 | Shinichi OKA | Pulmonary Complications in Patients with AIDS |
AIDS | Vol.78 No.11 | 717-722 | Chairpersons:F.YAMAGISHI and K.SHIMOKATA | Tuberculosis in Compromised Hosts |
AIDS | Vol.81 No.11 | 673-679 | Arata KOCHI | The Comparison of Treatment between TB, AIDS, and Malaria from Public Health Perspective |
AIDS | Vol.82 No.11 | 845-848 | Takuma SHIRASAKA | Diagnosis and Treatment of Tuberculosis or Mycobacterium avium-intracellulare Complex Infection in HIV-Infected Patients |
AIDS | Vol.85 No.10 | 747-756 | Atsuyuki KURASHIMA et al. | A NEW ANTI-MYCOBACTERIAL AGENT, RIFABUTIN |
Air born disease | Vol.78 No.05 | 395-399 | Naomi SEKI | A Suspected Case of Mass Outbreak of Tuberculosis Infection in a Small Company Separated into Two Floors |
Air exchange | Vol.79 No.09 | 509-518 | Masakazu AOKI | Transmission of Tuberculosis(I) |
Airborne infection | Vol.79 No.09 | 509-518 | Masakazu AOKI | Transmission of Tuberculosis(I) |
Airborne infection | Vol.80 No.05 | 401-411 | Masakazu AOKI | Transmission of Tuberculosis(III) |
Airborne infection | Vol.81 No.01 | 27-34 | Masakazu AOKI | Risk Management of Tuberculosis in Medical Institutions |
Airborne infection model | Vol.80 No.06 | 461-467 | Hirotoshi WATASE | The Transmission of Tuberculosis in a Cram School |
Airflow | Vol.86 No.05 | 487-491 | Kenji MATSUMOTO et al. | AN OUTBREAK OF TUBERCULOSIS IN WHICH ENVIRONMENTAL FACTORS INFLUENCED TUBERCULOSIS INFECTION |
Airin | Vol.82 No.05 | 455-458 | Nobuaki NAKATA et al. | Significance of Tuberculosis Screening of Outpatients in Areas with High Prevalence of Tuberculosis |
Albumin | Vol.76 No.09 | 619-624 | Mouka TAMURA et al. | A Study on Relation between Active Pulmonary Tuberculosis and Underlying Diseases |
Alignment with health centers | Vol.80 No.04 | 381-388 | Keiichi HOSHINO et al. | Usefulness of Support during Treatment by Alignment with Health Centers and DOT during Hospitalization |
Allergic diseases | Vol.77 No.02 | 87-93 | Kenji NAKANISHI | Regulation of Th1 and Th2 Immune Responses by IL-18 |
Amendment of Tuberculosis Prevention Law | Vol.80 No.07 | 541-546 | Mitsuhiro USHIO | Amendment of Tuberculosis Prevention Law and Prospect of Tuberculosis Control Program |
Amenity | Vol.87 No.06 | 475-480 | Kunihiko ITO et al. | NATIONWIDE SURVEY OF SUITABILITY OF TUBERCULOSIS WARDS FOR IN-HOSPITAL CARE OF TUBERCULOSIS PATIENTS |
Aminoglycoside | Vol.87 No.10 | 641-647 | Kinuyo CHIKAMATSU et al. | EVALUATION OF GenoType® MTBDRsl FOR TESTING RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS ISOLATES TO FLUOROQUINLONE, AMINOGLYCOSIDE, AND ETHAMBUTOL |
Amnesia | Vol.79 No.08 | 469-473 | Yusuke SHIKAMA et al. | Acute Onset of Somnolence and Amnesia Due to Cerebral Infarction of Bilateral Thalamus Accompanied with Tuberculous Meningitis:A Case Report |
Amplicor | Vol.77 No.06 | 449-455 | Yoshimi HIGURASHI et al. | Reliability of Amplicor® Mycobacteria Kit for Detection of Mycobacterium tuberculosis Complex and Mycobacterium intracellulare:Results of Cooperative Study Among 331 Laboratories in 2000 |
Amplicor Mycobacterium Tuberculosis Test | Vol.75 No.12 | 691-697 | Kunihiko ITO et al. | Limits of Nucleic Acid Amplification Tests for Diagnosis of Smear Negative Pulmonary Tuberculosis |
Amplified Mycobacterium Tuberculosis Direct Test | Vol.75 No.12 | 691-697 | Kunihiko ITO et al. | Limits of Nucleic Acid Amplification Tests for Diagnosis of Smear Negative Pulmonary Tuberculosis |
Angio-sarcoma | Vol.84 No.07 | 531-534 | Miwako SAITOU et al. | A Case of Pyothorax-Associated Pleural Angiosarcoma Diagnosed by Autopsy |
Annual change | Vol.86 No.05 | 515-521 | Shiomi YOSHIDA et al. | PRESENT STATUS OF STUDIES ON EPIDEMIOLOGY AND MOLECULAR EPIDEMIOLOGY OF MYCOBACTERIUM KANSASII, IN SPECIAL REFERENCE TO ITS EPIDEMIOLOGY |
Annual of the Pathological Autopsy Cases in Japan | Vol.77 No.04 | 355-360 | Hirofumi SUZUKI et al. | The Current Status and Problems of the Intestinal Tuberculosis Through a review of the Annual of the Pathological Autopsy Cases in Japan |
Annual risk of tuberculosis infection | Vol.76 No.08 | 571-579 | Naohiro NAGAYAMA | Tuberculosis in Japan at Present and in Near Future |
Annual risk of tuberculosis infection in Japan | Vol.80 No.05 | 401-411 | Masakazu AOKI | Transmission of Tuberculosis(III) |
Annual trend | Vol.87 No.09 | 585-589 | Tuberculosis Surveillance Center (TSC), RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2010 ―(4) Tuberculosis in the Elderly― |
Anti TBGL (tuberculous glycolipid) antibody | Vol.77 No.02 | 73-77 | Junko ASHINO et al. | A Case of Disseminated Tuberculosis Requiring Extended Period for the Identification of Mycobacterium tuberculosis on Culture |
Anti tumor necrosis factor-α | Vol.78 No.10 | 661-667 | Fumio YAMAGISHI | Measures for Tuberculosis in Compromised Hosts-Mainly on Chemoprophylaxis- |
Antifungal drugs | Vol.86 No.09 | 781-785 | Shigenori ISHIKAWA et al. | CLINICAL ANALYSIS OF NON-TUBERCULOUS MYCOBACTERIOSIS CASES COMPLICATED WITH PULMONARY ASPERGILLOSIS |
Antigen discovery | Vol.80 No.08 | 581-585 | Peter ANDERSEN et al. | Replacing the Tuberculin Skin Test with a Specific Blood Test |
Anti-infective drug | Vol.75 No.10 | 599-602 | Satoshi OMURA | Prospect of Chemotherapy in the 21st Century |
Antimicrobial activity | Vol.76 No.04 | 357-362 | Shin KAWAHARA et al. | Comparison of in vitro Antimicrobial Activities of Ofloxacin, Levofloxacin, Ciprofloxacin, and Sparfloxacin against Various Mycobacteria |
Anti-mycobacterial agent | Vol.85 No.10 | 747-756 | Atsuyuki KURASHIMA et al. | A NEW ANTI-MYCOBACTERIAL AGENT, RIFABUTIN |
Antimycobacterial susceptibility | Vol.81 No.04 | 329-335 | Hiromi ANO et al. | Antimycobacterial Susceptibility against Nontuberculous Mycobacteria Using BrothMIC NTM |
Antimycobacterial susceptibility test | Vol.77 No.02 | 61-66 | Miyako Higa et al. | Interpretive Compatibility of Antimycobacterial Susceptibility for Mycobacterium tuberculosis Determined by Proportion Test Method on Egg-Based Ogawa Media and Broth Microdilution Test, BrothMIC MTB |
Anti-retroviral treatment | Vol.84 No.04 | 203-211 | Norio YAMADA
and Hideaki NAGAI |
The Current and Future Situations of TB/HIV (Co-Infection of Tuberculosis and HIV) in Japan |
Antisense oligo DNA | Vol.78 No.01 | 33-35 | Toshiaki SHIMIZU et al. | Effects of Antisense Oligo DNA on the Antimicrobial Activity of Reactive Oxygen Intermediates and Antimycobacterial Agents Against Mycobacterium avium Complex |
Anti-tuberculosis agents | Vol.88 No.05 | 485-489 | Ayaka TAKAGI et al. | PRIMARY NASOPHARYNGEAL TUBERCULOSIS |
Anti-tuberculosis chemotherapy | Vol.77 No.07 | 527-531 | Yasuo ITOH et al. | A Case of Tuberculosis Pleuritis Developing Contralateral Pleural Effusion During Anti-Tuberculosis Chemotherapy, Falling into Chronic Respiratory Failure |
Anti-tuberculosis chemotherapy | Vol.82 No.10 | 771-781 | Masako WADA | Anti-Tuberculosis Chemotherapy |
Anti-tuberculosis chemotherapy | Vol.83 No.01 | 13-19 | Yugo KANEKO et al. | Drug-Induced Hepatotoxicity Caused by Anti-Tuberculosis Drugs in Tuberculosis Patients Complicated with Chronic Hepatitis |
Anti-tuberculosis drug | Vol.78 No.01 | 15-19 | Naoki MIYAZAWA et al. | Effect of Glycyrrhizin on Anti-Tuberculosis Drug-Induced Hepatitis |
Anti-tuberculosis drug | Vol.88 No.03 | 297-300 | Naoki MIYAZAWA et al. | COMPARISON OF DRUG-INDUCED HEPATITIS OCCURRING IN ELDERLY AND YOUNGER PATIENTS DURING ANTI-TUBERCULOSIS TREATMENT WITH A REGIMEN INCLUDING PYRAZINAMIDE |
Anti-tuberculosis drugs | Vol.87 No.06 | 469-474 | Minako MATSUBAYASHI et al. | TWO CASES OF TUBERCULOUS UVEITIS |
Anti-tuberculosis drug susceptibility test | Vol.87 No.12 | 783-787 | Tuberculosis Surveillance | TUBERCULOSIS ANNUAL REPORT 2010 ─ (7) Tuberculosis Characteristics upon Diagnosis-2 ─ |
Anti-tuberculosis drug susceptibility testing | Vol.82 No.05 | 449-454 | Satoshi MITARAI et al. | Comparative Study of BACTEC MGIT 960 AST and Conventional Proportion Method Using Ogawa Medium for the Drug Susceptibility Testing of Mycobacterium tuberculosis to Isoniazid |
Anti-tuberculosis drug-induced hepatitis | Vol.80 No.09 | 607-611 | Masako WADA | Anti-tuberculosis Drug-Induced Hepatitis |
Antituberculosis drugs | Vol.79 No.01 | 7-10 | Shuichi YANO et al. | The Usefulness of Lymphocyte Stimulation Test (LST) in Side Effects of Antituberculosis Drugs |
Antituberculosis drugs | Vol.83 No.01 | 13-19 | Yugo KANEKO et al. | Drug-Induced Hepatotoxicity Caused by Anti-Tuberculosis Drugs in Tuberculosis Patients Complicated with Chronic Hepatitis |
Antituberculous drugs | Vol.85 No.11 | 809-813 | Haruaki TOMIOKA | PROSPECTS FOR THE DEVELOPMENT OF NEW ANTITUBERCULOUS DRUGS PUTTING OUR HOPES ON NEW DRUG TARGETS |
Antituberculosis drugs | Vol.86 No.05 | 499-507 | Yoshiaki YAMAMOTO et al. | RETROSPECTIVE COHORT STUDY OF RISK FACTORS FOR ADVERSE EFFECTS OF ANTITUBERCULOUS THERAPY |
Anti-tuberculosis drugs | Vol.78 No.04 | 339-346 | Naohiro NAGAYAMA et al. | Secular Increase in the Incidence Rate of Drug-Induced Hepatitis Due to Anti-Tuberculosis Chemotherapy Including Isoniazid and Rifampicin |
Anti-tuberculosis drugs | Vol.82 No.05 | 467-473 | Eriko SHIGETO et al. | A Survey of Anti-Tuberculosis Drug-Induced Severe Liver Injury in Japan |
Antituberculous activity | Vol.81 No.04 | 337-344 | Atsuhiko TADA et al. | In vitro Antituberculous Activity of Ofloxacin and Levofloxacin against Multidrug-Resistant Tuberculosis and Clinical Outcomes |
Antituberculous chemotherapy | Vol.81 No.08 | 531-535 | Yoshihito IWAHARA et al. | Transient Worsening of Chest Radiograph and Development of Lymphadenopathy during Chemotherapy for Miliary Tuberculosis |
Antituberculous drug | Vol.77 No.12 | 771-775 | Yoshihiro KOBASHI et al. | Clinical Evaluation of the Cause of Death in Patients with Active Pulmonary Tuberculosis |
Anti-tuberculous drug | Vol.81 No.07 | 457-465 | Akira SAITO et al. | Tuberculosis Complicated with Liver Cirrhosis |
Anti-tuberculous drug | Vol.82 No.09 | 705-709 | Yoshitaka HARADA et al. | A Case of Fatal Liver Failure Due to Anti-Tuberculous Therapy |
Antituberculous drugs | Vol.75 No.12 | 699-704 | Yoshihiro KOBASHI et al. | Desensitization Therapy for Allergic Reactions of Antituberculous Drugs-Evaluation of Desensitization Therapy According to the Guideline of the Japanese Society for Tuberculosis |
Antituberculous drugs | Vol.76 No.09 | 635-639 | Shuichi YANO et al. | The Effectiveness of Steroid as Adjunctive Therapy in the Management of Two Patients with Febrile Reaction Due to Antituberculous Drugs |
Antituberculous drugs | Vol.77 No.06 | 435-441 | Yoshihiro KOBASHI et al. | The Effect of Combined Chemotherapy Following the Guidelines on Treatment for Mycobacterium avium Complex Pulmonary Disease |
Antituberculous drugs | Vol.77 No.08 | 573-584 | Haruaki TOMIOKA | Prospects for Development of New Antituberculous Drugs |
Antituberculous drugs | Vol.81 No.01 | 35-50 | Chairpersons:M. SAKATANI and Y. NAKAJIMA | Treatment of Non-Tuberculous Pulmonary Mycobacteriosis |
Antituberculous drugs | Vol.81 No.12 | 753-774 | Chairpersons:H. TOMIOKA and K. NAMBA | Development of Antituberculous Drugs:Current Status and Future Prospects |
Antituberculous drugs | Vol.85 No.02 | 113-123 | Haruaki TOMIOKA and Atsuhiko TADA | CAN WE HAVE
ADEQUATE CHEMOTHERAPY REGIMENS FOR TUBERCULOSIS IN THE FUTURE ? |
Antituberculous drugs | Vol.75 No.09 | 521-526 | Yoshihiro KOBASHI et al. | Desensitization Therapy for Antituberculous Drugs |
Antituberculosis drugs | Vol.86 No.02 | 87-99 | Chairpersons: K. TSUYUGUCHI and M. WADA |
MANAGEMENT OF ADVERSE EFFECTS WITH ANTITUBERCULOSIS CHEMOTHERAPY |
Antituberculosis drugs | Vol.86 No.09 | 773-779 | Makiko KUNOGI et al. | EVALUATION OF TUBERCULOSIS TREATMENT INCLUDING LEVOFLOXACIN (LVFX) IN CASES WHO COULD NOT CONTINUE STANDARD REGIMEN |
Anti-tuberculous immunity | Vol.76 No.12 | 741-747 | Atsushi SAITO | A Putative Immunotherapy with Biological Response Modifiers(BRM) against Intractable Pulmonary Tuberculosis |
Anti-tuberculous immunity | Vol.78 No.01 | 51-55 | Chairpersons:M. MITSUYAMA, K. AKAGAWA | Up-To-Date Understanding of Tuberculosis Immunity |
Anti-tumor necrosis factor-α | Vol.80 No.10 | 647-653 | Fumio YAMAGISHI | Chemoprophylaxis |
Anti-tumor necrosis factor-α | Vol.81 No.10 | 631-638 | Fumio YAMAGISHI | The Clinical Features for Tuberculosis in Compromised Hosts |
Anxiety | Vol.77 No.06 | 457-463 | Yoichi NAKANISHI et al. | Questionnaire About Impression and Knowledge of Tuberculosis in Employees and Students in a University Hospital |
Apoptosis | Vol.81 No.11 | 687-691 | Ikuo KAWAMURA | Protective Immunity against Mycobacterium tuberculosis |
Apoptosis | Vol.85 No.06 | 539-546, | Ikuo KAWAMURA | Protective Immunity against Mycobacterium Tuberculosis |
Appetite loss | Vol.76 No.06 | 447-454 | Yasuhiro YAMAGUCHI et al. | A Study on the Clinical Features of Pulmonary Tuberculosis in Elderly Patients |
Application | Vol.86 No.12 | 983-1003 | Chairpersons: 1 Nobuyuki HARADA and 2 Yoshihiko HOSHINO | The 86th Annual Meeting Mini-Symposium - NEW MOVEMENT OF IGRA |
Appropriate use | Vol.78 No.10 | 653-659 | Tadashi ISHIDA | Role of Oral Fluoroquinolones in Patients with Respiratory Diseases |
ARDS | Vol.76 No.01 | 1-8 | Naohiro NAGAYAMA et al. | The Causes of Death in Patients with Non-MDR Pulmonary Tuberculosis in Our Hospital |
ARDS | Vol.77 No.11 | 729-733 | Yuko ITO et al. | A Case of Multidrug-Resistant Tuberculosis (MDR-TB) in Young Female Complicated with Acute Respiratory Distress Syndrome and Developing Multiple Giant Cysts and Pneumothorax in Both Lung |
ARMS-PCR | Vol.86 No.02 | 61-68 | Kenji OGAWA | GENETIC RESEARCH ABOUT MYCOBACTERIUM AVIUM COMPLEX |
ARMS‑PCR method | Vol.88 No.01 | 17-22 | Kenji OGAWA | GENETIC RESEARCH ABOUT MYCOBACTERIUM AVIUM COMPLEX |
Ascites | Vol.76 No.06 | 479-484 | Hiroshi MIZUTANI et al. | A case of Tuberculous Peritonitis Diagnosed by a Direct Smear of Ascitic Fluid Complicated with an Active Pulmonary Tuberculosis and Intestinal Tuberculosis |
Ascites | Vol.80 No.01 | 15-18 | Hirokazu TANIGUCHI et al. | A Case of Tuberculous Peritonitis Showing a Rapid Increase of Bilateral Pleural Effusion |
Ascites | Vol.87 No.12 | 765-769 | Takeharu KOGA et al. | A CASE OF TUBERCULOUS PERITONITIS ACCOMPANIED BY LYMPHADENITIS IN A PATIENT WITH LIVER CIRRHOSIS IN WHICH LYMPH NODE BIOPSY WAS USEFUL FOR ESTABLISHING THE DIAGNOSIS |
Asia | Vol.77 No.10 | 693-697 | Chairpersons:M.SUCHI, S.TATENO | Tuberculosis in Asia |
Aspergillosis | Vol.86 No.12 | 911-915 | Yutsuki NAKAJIMA | The 86th Annual Meeting President Lecture - THE ROLE AND LANDSCAPE OF SURGICAL TREATMENT FOR MYCOBACTERIOSIS |
Assessment sheet of new discharge criteria for TB patients | Vol.82 No.11 | 837-844 | Jun MITSUISHI et al. | Investigation on the Changes in the Hospitalization Period after the Induction of New Discharge Criteria for Pulmonary Tuberculosis -Utility of Assessment Sheet for Using Clinical Path- |
Assignment | Vol.85 No.12 | 861-867 | Eriko SHIGETO | The 85th Annual Meeting Educational Lecture − FUTURE TUBERCULOSIS CARE IN JAPAN |
Assured treatment | Vol.79 No.01 | 17-24 | Yuki TADA et al. | Tuberculosis Control in Kawasaki City-Promoting the DOT Program |
Asymptomatic infection | Vol.81 No.09 | 581-588 | Naoyuki MIYASHITA | Chlamydia pneumoniae Infections |
Atelectasis | Vol.77 No.04 | 373-376 | Yoshiyuki ABE. et al. | A Case of Multidrug-Resistant(MDR) Tuberculosis with Collapse of the Left Lung After Hemoptysis |
Atelectatic induration | Vol.78 No.11 | 699-704 | Syeiyu HIRATA et al. | An Adult Case of Hypoplasia of the Left Lung Disclosed by Pneumonectomy for Pulmonary M.avium Complex Infection Associated with Intractable Pneumothorax |
Atherosclerosis | Vol.79 No.01 | 25-32 | Ryuzo KAWAMORI | Diabetes and Tuberculosis-Bad Companions- |
Atherosclerosis | Vol.81 No.09 | 581-588 | Naoyuki MIYASHITA | Chlamydia pneumoniae Infections |
Atypical mycobacteriosis | Vol.76 No.07 | 519-524 | Takesuke HIRAOKA et al. | The Alternative or Simultaneous Excretion of Different Species of Mycobacteria in Alypical Mycobacteriosis-15 Cases in 7 Years- |
Atypical mycobacteriosis | Vol.76 No.07 | 525-531 | Yoshinari KITAHARA et al. | Pulmonary Mycobacterium kansasii Infection in the Southern Area of Fukuoka Prefecture |
Atypical mycobacteriosis | Vol.79 No.07 | 431-435 | Tetsuro INOUE et al. | Clinical Ebaluation on Isolation of Mycobacterium kansasii in Our Hospital |
Atypical mycobacteriosis | Vol.79 No.09 | 573-577 | Tetsuro INOUE et al. | Pulmonary Mycobacterium fortuitum Infection with Multiple Nodular Shadows in a Healthy man |
Atypical mycobacteriosis | Vol.80 No.01 | 25-30 | Mitsunori SAKATANI | The Non-tuberculous Mycobacteriosis |
Atypical mycobacterium | Vol.78 No.09 | 601-604 | Chairpersons:A. WATANABE and Y. NIKI | Role of New Quinolones in the Treatment of Mycobacteriosis |
Atypical pneumonia | Vol.81 No.08 | 543-549 | Akira WATANABE | Clinical Manifestation of Q Fever and Tuberculosis, Similarly Caused by Intracellular Parasites |
Automated inhalation exposure apparatus | Vol.75 No.07 | 463-469 | Isamu SUGAWARA et al. | Optimal Conditions for Establishment of Experimental Tuberculosis Model Using an Automated Inhalation Exposure Apparatus and Its Application |
Autophagy | Vol.81 No.11 | 687-691 | Ikuo KAWAMURA | Protective Immunity against Mycobacterium tuberculosis |
Autopsy | Vol.82 No.03 | 165-171 | Hitoshi HOSHINO et al. | Evaluation of Accuracy of Clinical Diagnosis of TB by Annual Autopsy Report |
Autopsy | Vol.84 No.07 | 531-534 | Miwako SAITOU et al. | A Case of Pyothorax-Associated Pleural Angiosarcoma Diagnosed by Autopsy |
Aveolar epithelial cell | Vol.85 No.06 | 523-530, | Hiroyuki SAIGA
amd Kiyoshi TAKEDA |
Potential of Novel Antimycobacterial Immune Factors, SLPI and Lipocalin2 |
Average stay in a hospital | Vol.77 No.01 | 3-9 | Tadao SHIMAO | How Beds for Tuberculosis be Provided and Utilized? |
Avian Influenza | Vol.80 No.11 | 701-708 | Nobuhiko OKABE | Present Situation and Control on Emerging Respiratory Infectious Diseases Such as SARS and Avian Influenza |
Axillary lymph node tuberculosis | Vol.84 No.07 | 541-544 | Kanako KOBAYASHI et al. | A Case of Axillary Lymph Node Tuberculosis with Paradoxical Worsening in Breast Lesion |